Recombinant Human Prostatic Acid Phosphatase/ACPP protein (His tag)

Recombinant Human Prostatic Acid Phosphatase/ACPP protein (His tag)
SKU
ELSPDEH100288-100
Packaging Unit
100 µg
Manufacturer
Elabscience Biotechnology

Availability: loading...
Price is loading...
Abbreviation: ACPP

Target Synonym: Prostatic Acid Phosphatase;PAP;5'-Nucleotidase;5'-NT;Ecto-5'-Nucleotidase;Thiamine Monophosphatase;TMPase;ACPP;ACP-3;ACP3

Target Species: Human

Expression Host: E.coli

Fusion Tag: N-His

UNIProt ID: P15309

Background: Prostatic acid phosphatase (PAP, or ACPP), also known as prostatic specific acid phosphatase (PSAP), is an enzyme produced by the prostate. As a non-specific phosphomonoesterase, Prostatic acid phosphatase synthetized and secreted into seminal plasma under androgenic control. The enzyme is a dimer of molecular weight around 100 kDa. Prostatic acid phosphatase is a clinically important protein for its relevance as a biomarker of prostate carcinoma. Furthermore, it has a potential role in fertilization. The major action of PAP is to dephosphorylate macromolecules with the help of catalytic residues (His(12) and Asp(258)) that are located in the cleft between two domains. Cellular prostatic acid phosphatase (cPAcP), an authentic tyrosine phosphatase, is proposed to function as a negative growth regulator of prostate cancer (PCa) cells in part through its dephosphorylation of ErbB-2. cPAcP functions as a neutral protein tyrosine phosphatase (PTP) in prostate cancer cells and dephosphorylates HER-2/ErbB-2/Neu (HER-2: human epidermal growth factor receptor-2) at the phosphotyrosine (p-Tyr) residues. Injection of the secretory isoform of PAP has potent antinociceptive effects in mouse models of chronic pain. This enzyme exhibits ecto-5'-nucleotidase activity, is widely distributed, and implicated in the formation of chronic pain. Additionally, PAP could be a target molecule in specific immunotherapy for patients with nonprostate adenocarcinomas including colon and gastric cancers.

Sequence: Lys 33-Asp 386

Purity: > 95 % as determined by reducing SDS-PAGE.

Formulation: Lyophilized from sterile PBS, pH 7.4.
Normally 5 % - 8 % trehalose, mannitol and 0.01% Tween80 are added as protectants before lyophilization.
Please refer to the specific buffer information in the printed manual.

Endotoxin: Please contact us for more information.
More Information
SKU ELSPDEH100288-100
Manufacturer Elabscience Biotechnology
Manufacturer SKU ELA-PDEH100288-100
Package Unit 100 µg
Quantity Unit STK
Product information (PDF) Download
MSDS (PDF) Download